This article is rated B-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects:

Pharmacology Mid‑importance This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles Mid This article has been rated as Mid-importance on the project's importance scale. Medicine Low‑importance This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles Low This article has been rated as Low-importance on the project's importance scale. Physiology Low‑importance This article is within the scope of WikiProject Physiology, a collaborative effort to improve the coverage of Physiology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PhysiologyWikipedia:WikiProject PhysiologyTemplate:WikiProject PhysiologyPhysiology articles Low This article has been rated as Low-importance on the importance scale. This article has been classified as relating to the kidneys and renal physiology.

A fact from Discovery and development of angiotensin receptor blockers appeared on Wikipedia's Main Page in the Did you know column on 22 November 2008 ( check views). The text of the entry was as follows: Did you know... that the antihypertensive drug Losartan becomes a more potent blocker of angiotensin receptors after it is metabolised in the body? A record of the entry may be seen at Wikipedia:Recent additions/2008/November.

A merge with the Angiotensin II receptor antagonist article may be a good idea. We don't need two separate articles. -- PFHLai ( talk) 15:39, 17 November 2008 (UTC) reply

This article was written as a part of a school project and we weren't allowed to base it on a page that already excisted. I actually think this one is much better than the Angiotensin II receptor antagonist article. But merge is not a bad idea.-- Elinborgus

Yes, it's much, much better. :-) Please see WT:PHARM#University project?. -- PFHLai ( talk) 13:24, 18 November 2008 (UTC) reply

In my opinion it is not critical to merge. It is a very interestring story. By the way, there is a small mistake on the structure of eprosartan. There is no peroxyde group on that molecule. -- Chemistlanglois 3:35, 20 november 2011